You are in:Home/Publications/Current Use of Adenovirus Vectors and Their Production Methods | |
Ass. Lect. Ekramy El-sayed Tawfeik Sayed Ahmed :: Publications: |
Title: | Current Use of Adenovirus Vectors and Their Production
Methods |
Authors: | Ekramy E. Sayedahmed, Rashmi Kumari, and Suresh K. Mittal |
Year: | 2019 |
Keywords: | Adenovirus vector, Gene delivery system, Gene therapy, Vector design, Vector production, Recombinant vaccines |
Journal: | Not Available |
Volume: | Not Available |
Issue: | Not Available |
Pages: | Not Available |
Publisher: | Not Available |
Local/International: | Local |
Paper Link: | Not Available |
Full paper | Ekramy El-sayed Tawfeik Sayed Ahmed_2019_Book_ViralVectorsForGeneTherapy.pdf |
Supplementary materials | Not Available |
Abstract: |
Various adenovirus (AdV) vector systems have proven to be lucrative options for gene delivery. They can serve as potential vaccine candidates for prevention of several common infectious diseases and hold the promise for gene therapy, especially for cancer. Several AdV vector-based therapies are currently at various stages of clinical trials worldwide, which make an immense interest of both the clinicians and researchers. Since these vectors are easy to manipulate, have broad tropism, and have the capability to yield high titers, this delivery system has a wide range of applications for different clinical settings. This chapter emphasizes on some of the current usages of AdV vectors and their production methods. |